Hormone Battle: Big Pharma vs. Small Biz

The debate surrounding prescription hormones for women has pitted drug company Wyeth against small pharmacies and makers of alternative therapies

Over the last four years, medical experts have been doing battle when it comes to the dangers of prescription hormones for women. A major study four years ago suggested that taking such hormones, the bulk made by Big Pharma company Wyeth (WYE), could lead to increased risk of breast cancer and heart problems. Now a new study, just out in the Journal of the American Medical Association and similarly replete with controversy, suggests that the risks were overstated.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.